BenzE. J., “Disorders of Hemoglobin,” in FauciA. S., Harrison's Principles of Internal Medicine, 17th ed. (New York: McGraw-Hill Medical, 2008).
2.
AdamsR. J., “Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography,”New England Journal of Medicine339 (1998): 5–11.
3.
AdamsR. J., “The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease,”New England Journal of Medicine326 (1992): 605–610;.
4.
AdamsR. J.BrambillaD. J.GrangerS.GallagherD.VichinskyE.AbboudM. R.PegelowC. H.WoodsG.RohdeE. M.NicholsF. T.JonesA.LudenJ. P.BowmanL.HagnerS.MoralesK. H., E. S. Roach for the STOP Study Investigative Team, “Stroke and Conversion to High Risk in Children Screened with Transcranial Doppler Ultrasound during the STOP Study,”Blood103 (2004): 3689–3694.
5.
See Adams, supra note 2.
6.
GoldsteinL.AdamsR. J.FurbergC. D.GorelickP. B.HademenosG.HillM.HowardG.HowardV. J.JacobsB.LevineS. R.MoscaL.SaccoR. L.ShermanD. G.WolfP. A.del ZoppoG. J., “AHA Scientific Statement; Primary Prevention of Ischemic Stroke, A Statement for Healthcare Professionals from the Stroke Council of the American Heart Association,”Circulation113, no. 24 (2006): e873–e923.
7.
See Adams, supra note 2.
8.
EckrichM. J.WangW. C.YangE.ArbogastP. G.MorrowA.DudleyJ. A.RayW. A.CooperW. O., “Adherence to Transcranial Doppler Screening Guidelines among Children with Sickle Cell Disease,”Pediatric Blood Cancer (2012).
9.
SwotaA. H.BradfieldS. M., “‘STOP’-ping Harm: When Is State Intervention Justified?”Pediatric Blood Cancer54, no. 1 (2010): 8–10.
10.
Id.
11.
CatlinA., “The Dilemma of Jehovah's Witness Children Who Need Blood to Survive,”HEC Forum8, no. 4 (1996): 195–207.
12.
AdamsR. J., “Should TCD Be Used to Force Parents to Allow Transfusion?”Pediatric Blood Cancer54, no. 1 (2010): 11–12.
